EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

P110 Inhibits DRP1/FIS1-Mediated Mitochondrial Fission to Alleviate Uric Acid–Induced Apoptosis in HK-2 Cells

Yuli Shen, Geng Huang, Yu Liu, Fulin Pan, Canling Long, Jia Liu, Zhigang Ma

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl46700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Yuli Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Rheumatology Department, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang …. Hauptthemen laut MEDLINE: Apoptosis, Dynamins, Mitochondrial Dynamics, Mitochondrial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Longgang District Science and Technology Innovation Special Fund of Shenzhen, Longgang Medical Discipline Construction Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperuricemic nephropathy is associated with mitochondrial dysfunction. Dynamin-related protein 1 (DRP1), a key regulator of mitochondrial fission, is activated under stress and translocates to the mitochondria, where it interacts with adapter proteins such as mitochondrial fission 1 protein (FIS1), thereby promoting excessive mitochondrial fission and apoptosis. Recent research has shown that inhibiting the DRP1/FIS1 interaction can reduce cellular injury in various disease models; however, its role in hyperuricemic nephropathy is unclear.

Methods

An in vitro model of hyperuricemic nephropathy was established by treating human renal tubular epithelial cells with uric acid (UA). Reverse transcription quantitative PCR and western blotting, and enzyme-linked immunosorbent assays were used to quantify the mRNA and protein levels of the target molecules. A specific peptide inhibitor, P110, was used to disrupt the binding between DRP1 and FIS1. Co-immunoprecipitation (Co-IP) was performed to confirm the interactions between DRP1 and FIS1. Cell viability was assessed using propidium iodide staining and the Cell Counting Kit-8 assay.

Results

UA significantly upregulated DRP1 expression, activated DRP1, and promoted mitochondrial translocation. P110 inhibited DRP1/FIS1 binding, preventing DRP1 UA-induced mitochondrial translocation. Excessive mitochondrial fission, reactive oxygen species generation, release of inflammatory factors, and apoptosis were significantly alleviated. In addition, inhibition of DRP1 mitochondrial translocation decreased the expression of apoptosis-related markers and apoptosis.

Conclusions

The overactivation of DRP1 is crucial for UA-induced renal tubular epithelial cell injury. P110 exerts a cytoprotective effect by inhibiting the DRP1/FIS1 interaction and modulating the mitochondrial apoptotic pathway. This study proposes a possible target for therapeutic intervention in the treatment of hyperuricemic nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisDynaminsMitochondrial DynamicsMitochondrial ProteinsUric AcidMembrane ProteinsHumansMitochondriaCell LineEpithelial CellsReactive Oxygen Species

Stichwörter der Autor:innen

apoptosisdynamin-related protein 1mitochondrial dysfunctionrenal tubular epithelial cellsuric acid

Substanzen

DynaminsDNM1L protein, humanMitochondrial ProteinsUric AcidFIS1 protein, humanMembrane ProteinsReactive Oxygen Species

Autor:innen und Institutionen

  • Nephrology and Rheumatology Department, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, 518172 Shenzhen, Guangdong, Ch…
  • Nephrology Department, The Chinese University of Hong Kong, Shenzhen Medical Center, 518172 Shenzhen, Guangdong, China.
  • Central Laboratory, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, 518172 Shenzhen, Guangdong, China.

Förderung

  • Longgang District Science and Technology Innovation Special Fund of Shenzhen
  • Longgang Medical Discipline Construction Fund

Zitieren

APA

Shen, Y., Huang, G., Liu, Y., Pan, F., Long, C., Liu, J., & Ma, Z. (2025). P110 Inhibits DRP1/FIS1-Mediated Mitochondrial Fission to Alleviate Uric Acid–Induced Apoptosis in HK-2 Cells. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46700

Vancouver

Shen Y, Huang G, Liu Y, Pan F, Long C, Liu J, et al. P110 Inhibits DRP1/FIS1-Mediated Mitochondrial Fission to Alleviate Uric Acid–Induced Apoptosis in HK-2 Cells. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46700

BibTeX
@article{Shen2025,
  author = {Shen, Yuli and Huang, Geng and Liu, Yu and Pan, Fulin and Long, Canling and Liu, Jia and Ma, Zhigang},
  title = {P110 Inhibits DRP1/FIS1-Mediated Mitochondrial Fission to Alleviate Uric Acid–Induced Apoptosis in HK-2 Cells},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl46700}
}
Kostenlos starten →